Skip to main content

Icosavax, Inc.

ICVXDelisted Feb 20, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001786255

Icosavax, Inc. was delisted on Feb 20, 2024; its insiders filed their last Form 4 on Feb 20, 2024; 93 institutions reported holding it in 13F filings for Q4 2023, worth $663.0M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Icosavax, Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ICVX: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders6264+2
Shares42.6M42.7M+89.2K (+0.2%)
Value$423.2M$331.0M−$92.2M (−21.8%)

New holders (8)

Institutions that held Icosavax, Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ICVX in Q3 2023
InstitutionSharesValue% of portfolio
Gsa Capital Partners LLP25,618$199.0K0.02%
State of Wisconsin Investment Board17,600$136.4K0.00%
American Century Companies Inc15,976$123.8K0.00%
SG Americas Securities, LLC14,539$113.0K0.00%
Federated Hermes, Inc.3,685$28.6K0.00%
Group One Trading, L.P.2,500$19.4K0.00%
Clearstead Advisors, LLC1,426$11.0K0.00%
Advisor Group Holdings, Inc.174$1.35K0.00%

Sold out (6)

Institutions that held Icosavax, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of ICVX in Q3 2023
InstitutionShares, Q2 2023Value, Q2 2023
HSBC Holdings PLC88,090$875.7K
Susquehanna International Group, LLP33,853$336.2K
Bank of Montreal29,876$310.4K
Two Sigma Investments, LP20,034$198.9K
Renaissance Technologies LLC15,400$153.0K
Raymond James Financial Services Advisors, Inc.10,361$102.9K